AbbVie (ABBV) Share-based Compensation (2012 - 2026)
AbbVie (ABBV) recorded Share-based Compensation of $160 million in Q3 2026, down 23.4% from $209 million a year earlier and down 3.6% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Share-based Compensation (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's Share-based Compensation came in at $927 million as of Sep 30, 2026, down 3.6% year-over-year; for FY2025, it was $955 million, up 4.8% from FY2024.
- Annual Share-based Compensation has increased for three straight years, with a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $911 million in FY2024 (+22.0%), $747 million in FY2023 (+11.3%), $671 million in FY2022 (-3.0%) and $692 million in FY2021 (-8.1%).
- Quarterly Share-based Compensation has ranged from $107 million in Q2 2022 to $444 million in Q1 2026 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in four of the last eight quarters, with growth averaging 2.5%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 67.3% in Q2 2023, against a decline of 32.7% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $166 million (Q2 2026), $444 million (Q1 2026) and $157 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 174.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 160.00 Mn |
| Jun 30, 2026 | 166.00 Mn |
| Mar 31, 2026 | 444.00 Mn |
| Dec 31, 2025 | 157.00 Mn |
| Sep 30, 2025 | 209.00 Mn |
| Jun 30, 2025 | 179.00 Mn |
| Mar 31, 2025 | 410.00 Mn |
| Dec 31, 2024 | 164.00 Mn |
| Sep 30, 2024 | 181.00 Mn |
| Jun 30, 2024 | 218.00 Mn |
| Mar 31, 2024 | 348.00 Mn |
| Dec 31, 2023 | 125.00 Mn |
| Sep 30, 2023 | 130.00 Mn |
| Jun 30, 2023 | 179.00 Mn |
| Mar 31, 2023 | 313.00 Mn |
| Dec 31, 2022 | 132.00 Mn |
| Sep 30, 2022 | 126.00 Mn |
| Jun 30, 2022 | 107.00 Mn |
| Mar 31, 2022 | 306.00 Mn |
| Dec 31, 2021 | 129.00 Mn |
API Access
AbbVie Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();